A strong stop loss program starts with a strong plan document. Clear, comprehensive language helps plan administrators make consistent benefit decisions, support appropriate care for members and manage potential financial exposure.
Applied behavior analysis (ABA) therapy is one area where that clarity is becoming increasingly important. As demand for autism services grows, licensing and oversight requirements continue to evolve and vary by state. Currently, 38 states have enacted licensing laws for behavior analysts. For brokers and their self-funded clients, this evolving environment reinforces the importance of clearly defined plan provisions and processes for reviewing ABA therapy.
Balancing access with appropriate oversight
Thoughtful oversight can help support appropriate care while giving plan administrators greater clarity and confidence. A well-defined plan document can help members access high-quality, evidence-based treatment while providing a framework for evaluating medical necessity, treatment plans and ongoing progress. Regular clinical reviews can also help ensure that the level and method of treatment continue to align with a member's individual needs.
A recent Symetra claim illustrates the potential value of this approach. An adult dependent was receiving online ABA therapy from a provider located more than 2,000 miles away, with original billed charges exceeding $980,000. Following the terms of the plan document, the plan administrator engaged case management and requested documentation supporting the medical necessity of the billed services. After this review, approximately $122,000 was ultimately paid for the services incurred.
This example underscores how a strong plan document and a diligent review process can help plan administrators support appropriate care while protecting the plan and its members from unsupported or inappropriate billing.
What should brokers and their clients consider?
Rather than waiting until a high-cost ABA claim occurs, brokers can help clients review their plan document and administrative process in advance. Important considerations may include:
- Provider qualifications: Does the plan clearly define applicable provider credentialing, accreditation and licensing requirements
- Individualized treatment plans: Is there a process for obtaining documentation that supports the recommended course of treatment?
- Medical necessity: Does the plan provide a framework for reviewing whether services meet applicable medical-necessity requirements?
- Ongoing clinical review: Are treatment plans and therapy hours reviewed periodically to determine whether they continue to be appropriate for the member?
- Progress documentation: Is the provider able to provide the plan administrator or TPA with information demonstrating treatment progress?
- Care delivery: Does the review process consider how services are delivered, including the use of telehealth, and whether the approach is appropriate for the member's circumstances?
- Coordination and case management: Is there a process for involving appropriate clinical or case management resources when additional review may be beneficial?
These considerations are intended as a practical framework for reviewing whether plan document provisions and administrative processes clearly address ABA therapy benefits. Any review should take into account the plan's terms, as well as applicable federal, state, and local laws and regulations, which may vary by jurisdiction.
The broker opportunity
Brokers can play an important role by encouraging clients to review plan language before an issue arises. Establishing clear expectations around provider qualifications, medical necessity, documentation and ongoing review can help reduce uncertainty for everyone involved—the member, provider, administrator and employer.
As ABA therapy continues to evolve, helping clients prepare today can lead to greater clarity and confidence when complex claims arise.
Did you know?
Symetra facilitates policyholder access to The Phia Group’s expertise in plan document review, compliance and guidance and regulatory support for self-funded health plans.